arrow
M

Massimo Di Maïo

Azienda Ospedaliera Città della Salute e della Scienza di Torino
H指数:66
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global management of drug–drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist

前列腺癌患者中药物-药物相互作用的全球管理:Meet-URO小组和ONCOassist进行的国际调查

2026-09-160
OAAI
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations

奥拉帕利在全球真实世界中对具有同源重组修复改变的转移性去势抵抗性前列腺癌患者的疗效

2026-08-310
OAAI
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data

评估晚期癌症总生存获益:外部对照队列研究结合真实世界数据的作用

2026-02-110
OAAI
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis

最大限度雄激素阻断治疗前列腺癌患者骨折风险的系统文献回顾和meta分析

2026-01-260
PRE
Estimating the clinical benefit of metastases resection in liver-limited metastatic colorectal cancer: an IPD-based pooled analysis of nine randomized trials

评估肝转移性结直肠癌中转移灶切除的临床获益:一项基于IPD的九项随机试验的合并分析

2026-01-010
OA
Treatment guided by cerebral oximetry in mechanically ventilated newborns: a statistical analysis plan for step one of the SafeBoosC-IIIv randomised clinical trial

经脑氧饱和度监测指导治疗的机械通气新生儿:SafeBoosC-IIIv随机临床试验第一步的统计分析计划

2025-12-180
PRE
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis

免疫疗法在晚期非小细胞肺癌III期试验中,ORR与PFS与OS结局的相关性:系统评价与Meta分析

2025-12-160
OAAI
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study

叙事医学与患者报告结局测量指标的数字化整合以改善对转移性乳腺癌患者生活质量的理解:PERGIQUAL研究

2025-12-010
PRE
Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies

肿瘤学中的液体活检:意大利科学学会AIOM-SIAPEC/IAP-SIBioC-SIF赞助的德尔菲共识研究的结果

2025-12-010
PRE
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study

同源重组修复基因检测变量及前列腺癌患者的诊断路径:一项多中心队列研究

2025-12-010
PRE
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis

基于疾病体积的转移性激素敏感型前列腺癌最佳治疗方法: 系统评价和网络荟萃分析

2025-11-170
OA
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期GEP-NENs的管理临床实践指南:意大利医学肿瘤学会(AIOM)与意大利神经内分泌肿瘤学会(ITANET)合作,采用GRADE方法进行证据评估和推荐。

2025-11-120
OAAI
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers

遗传、流行病学、临床和治疗轨迹在结肠癌和直肠癌中的作用

2025-10-270
OAAI
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: a secondary endpoint of the ARMANI phase 3 trial

帕克他赛和雷莫芦单抗序贯维持治疗在晚期胃肠癌中的患者报告结局:ARMANI III期试验的次要终点

2025-10-200
PRE